51²è¹Ý

Skip to content
Reading time: < 1 minute
hand holding seaweed
Dictyota sp.

A limu (seaweed) native to Hawaiian waters, Dictyota sp., is gaining attention for its potential to produce compounds that have high-value ingredients in pharmaceutical, nutraceutical, food processing, medical and dental industries. University of 51²è¹Ý at Mānoa researchers are exploring ways to establish an Indigenous limu commercial industry in the islands using the second of two $150,000 Sun Grant Western Region awards granted to Samir Khanal of the .

Although the limu is currently “unexplored” as an algal feedstock, Khanal of the 51²è¹Ý believes it could potentially launch a significant commercial industry—if researchers could figure out a way to boost its growth rate.

man holding seaweed
CTAHR graduate student Ty Shitanaka displays a clump of Dictyota sp.

“If we can develop a biorefinery, focused on this Indigenous Hawaiian seaweed, to produce high-value compounds while simultaneously remediating aquaculture effluent [waste], this will introduce sustainable macroalgal-based bioproducts to the 51²è¹Ý marketplace and create new avenues for a circular bioeconomy in the state,” said Khanal.

Creating a biorefinery

Khanal and his team of researchers including Surendra KC, Manpreet Kaur and graduate student Ty Shitanaka are using CO2-nanobubbles and aquaculture waste as a nutrient source.

The team¡¯s approach includes lab-scale experiments to optimize growth conditions, followed by pilot-scale cultivation trials. They plan to refine extraction methods for fucoidan (sulfated, fucose rich polysaccharides) and alginate (natural polymer), investigate potential applications for the limu¡¯s biomass residue—and most importantly—assess the economic potential of scaling up a Dictyota-based biorefinery.

“The outcomes of this project have the potential to develop larger extramural grants and strong collaborations between private and public institutions, with special emphasis on commercialization,” said Khanal.

Back To Top